Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.
about
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapiesPreclinical Evidence for the Efficacy of Ischemic Postconditioning against Renal Ischemia-Reperfusion Injury, a Systematic Review and Meta-AnalysisIschaemic conditioning: pitfalls on the path to clinical translationThe role of arginase and rho kinase in cardioprotection from remote ischemic perconditioning in non-diabetic and diabetic rat in vivo.Ischemic preconditioning in the animal kidney, a systematic review and meta-analysis.Ischemic conditioning: the challenge of protecting the diabetic heart.Remote ischemic conditioning.Modulation of signaling mechanisms in the heart by thioredoxin 1.Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heartSIRT1-mediated acute cardioprotection.Short-and long-term effects of ischemic postconditioning in STEMI patients: a meta-analysis.Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.Should the STAIR criteria be modified for preconditioning studies?Remote ischemic preconditioning in patients with intermittent claudication.Loss of myocardial protection against myocardial infarction in middle-aged transgenic mice overexpressing cardiac thioredoxin-1Cardioprotection during diabetes: the role of mitochondrial DNA.Autophagy as a therapeutic target for ischaemia /reperfusion injury? Concepts, controversies, and challenges.Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.What is the role of erythropoietin in acute myocardial infarct? Bridging the gap between experimental models and clinical trials.Cardioprotection against myocardial reperfusion injury: successes, failures, and perspectives.The role of post-translational modifications in acute and chronic cardiovascular disease.Myocardial protection from ischemia-reperfusion injury post coronary revascularization.Remote ischaemic conditioning-a new paradigm of self-protection in the brain.Drug-disease interactions: narrative review of aspirin in gastric ulcer.Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury.Delta Opioid Receptors and Cardioprotection.Impact of caloric restriction on myocardial ischaemia/reperfusion injury and new therapeutic options to mimic its effectsRepeated Remote Ischemic Conditioning Effect on Ankle-brachial Index in Diabetic Patients - A Randomized Control Trial.Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial.Effect of remote ischemic preconditioning in the elderly patients with coronary artery disease with diabetes mellitus undergoing elective drug-eluting stent implantation.Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonylurea-treated diabetics undergoing coronary revascularisation.Reperfusion injury in acute myocardial infarction.Coronary flow response to remote ischemic preconditioning is preserved in old cardiac patients.Pacing postconditioning: impact of pacing algorithm, gender, and diabetes on its myocardial protective effects.Ischemic postconditioning confers cardioprotection and prevents reduction of Trx-1 in young mice, but not in middle-aged and old mice.Exercise does not activate the β3 adrenergic receptor-eNOS pathway, but reduces inducible NOS expression to protect the heart of obese diabetic mice.Remote Ischemic Conditioning in Cerebral Diseases and Neurointerventional Procedures: Recent Research Progress.Remote ischemic conditioning: a promising therapeutic intervention for multi-organ protection
P2860
Q24289195-C35B7F12-67D6-47F1-AAB9-16150DA628F7Q26766521-5D476D41-E2B8-4513-B922-FC62E7DF010BQ27000466-6107C1AE-A7D1-4A4C-ABF8-2A17C987D2FBQ34070745-42AD9F67-AFFC-4390-B66A-3ADDD3D87216Q34184534-FD551FD4-4A7B-462C-890E-7C045660FC8AQ34457775-26F5F908-66D1-4ABE-A89C-31835C5656D8Q34458416-85B5988C-12AC-4BF9-8BF5-72F6AC4BFD22Q34547638-DE0594AF-97A1-43AA-A7F4-B2EBAB0FC666Q35286353-A6F0DA89-EE00-483D-9A63-FFBA179E2643Q35395805-5D0BAA02-4938-407F-BCD3-83AC79A4F3CBQ35843019-33046B10-EB47-4E3C-A58B-1CB2AE1DA949Q36288965-3A0D1B2F-4FE8-4AA3-8AFF-8584976BEA43Q36634396-278B6800-E0BB-4B51-934C-0DE8421CDC28Q36791645-D489C761-8030-4B40-83D8-2C998FA09A76Q37022039-70E1FB70-C29B-4278-B6B2-F2A528EDEF10Q37684565-F3F712D6-8C8B-4371-B341-49CF299B2FDEQ37973049-88E725F2-FA52-4F55-A4B2-E70F8808D527Q38075417-76EF6E0E-553B-47A2-B95F-55F28F744F3AQ38108537-87D66851-BDFC-407E-9A6B-72A3CBA6F1F0Q38124357-A6577232-9CF8-4433-B6B4-9CE1D5946CDEQ38222880-A4F11E9A-0699-434E-A7C8-A4FF12664D2EQ38552442-DBA36CFF-D4AC-4372-88B1-9F0970D369DAQ38639332-2A8CF731-FFC5-4817-B2B7-50F64CA9FD89Q38870495-5B4A8F95-4C10-4A06-AE86-AA8A04059C7DQ38903618-F438A6A1-5E09-4116-84BB-B629FDB8DC90Q38930128-8D8777C8-18BD-4A3C-9144-6E676D7C73E0Q39151222-A5161520-272A-4F52-BEC2-F67147E288A9Q40630534-A0F6B387-6BB6-46A0-ADBC-CE49BC3DAF98Q42314962-C0C2B4BF-2048-49E9-B484-924D58BF9BA4Q43758053-5814763F-5C9C-4DB4-9D58-E209FEACB114Q44763054-73D2607B-0BC0-4857-9757-A9981142C571Q46034115-07A4176A-0036-432C-8569-5D2FBBA85A82Q46146090-0C85E254-FBD2-414A-8616-3FD069977424Q46180817-9286A587-C2E0-4541-9395-008FF665A581Q50101215-FD64CAA4-9DC8-4626-A68A-E3F7C0B838ADQ50243642-90E18FD7-D158-4691-B3A0-C84729726BABQ53629285-D6258BEB-EC2E-40A3-B843-B3F944811910Q53786654-8C58010D-56F1-4634-87CC-7AB1B5D24F89Q54977065-6D0E07FE-E84F-4AD3-9B22-F6EEE2150E0FQ57168888-66BCAD4A-5672-4EBF-97DD-BFB23D24BA0E
P2860
Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy of cardioprotective ' ...... s: the co-morbidity conundrum.
@en
Efficacy of cardioprotective ' ...... s: the co-morbidity conundrum.
@nl
type
label
Efficacy of cardioprotective ' ...... s: the co-morbidity conundrum.
@en
Efficacy of cardioprotective ' ...... s: the co-morbidity conundrum.
@nl
prefLabel
Efficacy of cardioprotective ' ...... s: the co-morbidity conundrum.
@en
Efficacy of cardioprotective ' ...... s: the co-morbidity conundrum.
@nl
P2860
P1433
P1476
Efficacy of cardioprotective ' ...... s: the co-morbidity conundrum.
@en
P2093
Karin Przyklenk
P2860
P304
P356
10.2165/11587190-000000000-00000
P577
2011-05-01T00:00:00Z
P5875
P6179
1033719325